Neural correlates of mild behavioral impairment: a functional brain connectivity study using resting-state functional magnetic resonance imaging

Manuscript Number:

21-0628R1

Author(s):

Zahinoor Ismail, Teruyuki Matsuoka, Masaru Mimura, Jin Narumoto, Ellen Rubinstein, Hiroyuki Uchida, Daisuke Ueno

Disclosures

Zahinoor Ismail

Consulting Fees:
Otsuka/Lundbeck - outside the submitted work Paid to institution - Acadia, Biogen, Roche, Sunovion - all outside the submitted work

Teruyuki Matsuoka

Nothing to Disclose

Masaru Mimura

Lecture Fees:
Speaker’s honoraria from Byer Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Hisamitsu Pharmaceutical, Janssen Pharmaceutical, Kyowa Pharmaceutical, Mochida Pharmaceutical, MSD, Mylan EPD, Nihon Medi-physics, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Santen Pharmaceutical, Shire Japan, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin.
Grants
- Agency:
  Daiichi Sankyo
  Dates:
  April 2020
- Agency:
  Eisai
  Dates:
  April 2020
- Agency:
  Pfizer
  Dates:
  April 2020
- Agency:
  Shionogi
  Dates:
  April 2020
- Agency:
  Takeda
  Dates:
  April 2020
- Agency:
  Tanabe Mitsubishi
  Dates:
  April 2020
- Agency:
  Tsumura
  Dates:
  April 2020

Jin Narumoto

Nothing to Disclose

Ellen Rubinstein

Nothing to Disclose

Hiroyuki Uchida

Consulting Fees:
Advisory panel payments from Dainippon-Sumitomo Pharma

Lecture Fees:
Speaker’s honoraria from Otsuka Pharmaceutical, Dainippon-Sumitomo Pharma, Eisai, and Meiji-Seika Pharma
Grants
- Agency:
  Eisai
  Dates:
  2020/10/01
- Agency:
  Otsuka Pharmaceutical
  Dates:
  2020/10/01
- Agency:
  Dainippon-Sumitomo Pharma
  Dates:
  2020/10/01
- Agency:
  Daiichi Sankyo Company
  Dates:
  2020/10/01
- Agency:
  Mochida Pharmaceutical
  Dates:
  2020/10/01
- Agency:
  Meiji-Seika Pharma
  Dates:
  2018/10/01

Daisuke Ueno

Nothing to Disclose